Glaukos Corporation (GKOS): Price and Financial Metrics
Glaukos Corporation (GKOS)
Today's Latest Price: $58.25 USD
Updated Oct 23 7:00pm
Add GKOS to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 142 in Medical - Devices & Equipment
See all "A" rated Strong Buy stocks
GKOS Stock Summary
- GKOS's price/sales ratio is 11.84; that's higher than the P/S ratio of 88.12% of US stocks.
- With a year-over-year growth in debt of 222.71%, GLAUKOS Corp's debt growth rate surpasses 92.83% of about US stocks.
- In terms of twelve month growth in earnings before interest and taxes, GLAUKOS Corp is reporting a growth rate of 1,206.65%; that's higher than 98.46% of US stocks.
- Stocks that are quantitatively similar to GKOS, based on their financial statements, market capitalization, and price volatility, are CDNA, NEWR, LPSN, SVMK, and EPAY.
- GKOS's SEC filings can be seen here. And to visit GLAUKOS Corp's official web site, go to www.glaukos.com.
GKOS Stock Price Chart Interactive Chart >
GKOS Price/Volume Stats
| Current price | $58.25 | 52-week high | $70.96 |
| Prev. close | $57.87 | 52-week low | $23.31 |
| Day low | $57.40 | Volume | 541,533 |
| Day high | $58.29 | Avg. volume | 715,609 |
| 50-day MA | $48.81 | Dividend yield | N/A |
| 200-day MA | $44.60 | Market Cap | 2.60B |
Glaukos Corporation (GKOS) Company Bio
Glaukos Corporation develops and commercializes products and procedures designed for the treatment of glaucoma. The company was founded in 1998 and is based in Laguna Hills, California.
Loading social stream, please wait...